The global lung cancer genomic testing market is still in the nascent phase. Various companies are increasing investments in research and development to facilitate the development of lung cancer genomic testing, which is expected to further increase the adoption of lung cancer genomic tests. The lung cancer genomic testing medicine market was valued at $1,262.0 million in 2020 and is...